Studies have also implicated AR in modulating various other oncogenic signaling pathways (e.g., EGFR, ERBB2, β-catenin), offering more evidence for the importance of AR-signaling as it pertains to bladder cancer biology [94,95]. This evidence concerns the gene AR and urinary bladder cancer.